Retinopathy of Prematurity (ROP) is a sight-threatening disease representing one of the main disabling diseases affecting premature newborns. Presently, ROP is treated by surgical interventions and drug therapies are limited to the off-label use of a little amount of molecules approved for other pathologies.
A safety review of drugs used for the treatment of retinopathy of prematurity
Filippi, LucaPrimo
;Dal Monte, Massimo
Ultimo
2020-01-01
Abstract
Retinopathy of Prematurity (ROP) is a sight-threatening disease representing one of the main disabling diseases affecting premature newborns. Presently, ROP is treated by surgical interventions and drug therapies are limited to the off-label use of a little amount of molecules approved for other pathologies.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Drugs to treat ROP - revised.pdf
Open Access dal 22/09/2021
Tipologia:
Documento in Post-print
Licenza:
Creative commons
Dimensione
743.83 kB
Formato
Adobe PDF
|
743.83 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
